XML 37 R21.htm IDEA: XBRL DOCUMENT

Collaboration Agreements, In-Licensing Arrangements And Business Development Activities (Tables)

6 Months Ended

Jul. 02, 2021

Revenues under the collaboration agreement with Ipsen were as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
License revenues	$	33,656	$	33,597	$	56,107	$	51,546
Collaboration services revenues	57,265		19,320		68,620		30,407
Total	$	90,921	$	52,917	$	124,727	$	81,953

Revenues under the collaboration agreement with Takeda were as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
License revenues	$	2,097	$	22,946	$	3,398	$	22,946
Collaboration services revenues	4,024		2,195		8,159		3,264
Total	$	6,121	$	25,141	$	11,557	$	26,210

License revenues under the collaboration agreement with Genentech were as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Profits on U.S. commercialization	$	2,160	$	1,376	$	3,954	$	2,783
Royalty revenues on ex-U.S. sales	$	782	$	1,125	$	1,733	$	2,434